AmirAli Talasaz, Director, Co-Chief Executive Officer, on May 12, 2026, sold 50,000 shares in Guardant Health (GH) for $5,016,000. Following the Form 4 filing with the SEC, Talasaz has control over a total of 2,096,504 common shares of the company, with 2,096,504 controlled indirectly.
SEC Filing: